Pharmacokinetic and biodistribution studies of N -(2-hydroxypropyl) methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model

Ling Dong Quan, Fang Yuan, Xin Ming Liu, Jian Geng Huang, Yazen Alnouti, Dong Wang

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

N-(2-Hydroxypropyl)methacrylamide (HPMA) copolymer has been found to be arthrotropic (joint-targeting) in the adjuvant-induced arthritis (AA) rat model using magnetic resonance imaging (MRI). In this manuscript, we report the quantitative pharmacokinetics and biodistribution (PK/BD) of 125I-labeled HPMA copolymer-'dexamethasone conjugate (P-'Dex) in AA rats. Structural parameters of the prodrug such as the molecular weight (MW) and Dex content were found to have strong impact on the PK/BD profiles of P-'Dex. The increase of MW (14,000, 24,000, and 42,000 g/mol) and Dex content (0, 151, and 313 μmol/g) enhances the arthrotropism of P-'Dex. For the conjugate with highest MW and Dex content (P-'H-M W/Dex), the percentage of injected doses per gram (ID/g) of ankle synovial tissue at day seventh postadministration is 1% g -'1, which confirms P-'Dex as an arthrotropic macromolecular prodrug. For liver and spleen, the ID/g values are 0.51 and 3.64% g -'1, respectively. As an antigen-presenting organ, the sequestration of the prodrug by spleen may be explained by its abnormal enlargement associated with the systemic inflammatory disease model. Gradual reduction of spleen weight due to the inflammation resolution effect of P-'Dex may also contribute to the high ID/g values. Increase of Dex content and reduction of MW would increase P-'Dex distribution to kidney. The highest ID/g value for kidney at day seventh postadministration (0.91% g -'1) was found with P-'L-M w (MW = 14,000 g/mol, Dex content =288 μmol/g), which may suggest kidney tubuli reabsorption of the conjugates. The P-'Dex's distribution to heart and lung is minimum.

Original languageEnglish (US)
Pages (from-to)1041-1049
Number of pages9
JournalMolecular Pharmaceutics
Volume7
Issue number4
DOIs
StatePublished - Aug 2 2010

Fingerprint

Experimental Arthritis
Dexamethasone
Pharmacokinetics
Molecular Weight
Prodrugs
Spleen
Kidney
Ankle
Weight Loss
Joints
Magnetic Resonance Imaging
N-(2-hydroxypropyl)methacrylamide
Inflammation
Antigens
Lung
Liver

Keywords

  • HPMA copolymer
  • Rheumatoid arthritis
  • arthrotropism
  • biodistribution
  • dexamethasone
  • pharmacokinetics
  • prodrug

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery

Cite this

Pharmacokinetic and biodistribution studies of N -(2-hydroxypropyl) methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model. / Quan, Ling Dong; Yuan, Fang; Liu, Xin Ming; Huang, Jian Geng; Alnouti, Yazen; Wang, Dong.

In: Molecular Pharmaceutics, Vol. 7, No. 4, 02.08.2010, p. 1041-1049.

Research output: Contribution to journalArticle

@article{bb415d67850347b2a6384ccc0c459e1c,
title = "Pharmacokinetic and biodistribution studies of N -(2-hydroxypropyl) methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model",
abstract = "N-(2-Hydroxypropyl)methacrylamide (HPMA) copolymer has been found to be arthrotropic (joint-targeting) in the adjuvant-induced arthritis (AA) rat model using magnetic resonance imaging (MRI). In this manuscript, we report the quantitative pharmacokinetics and biodistribution (PK/BD) of 125I-labeled HPMA copolymer-'dexamethasone conjugate (P-'Dex) in AA rats. Structural parameters of the prodrug such as the molecular weight (MW) and Dex content were found to have strong impact on the PK/BD profiles of P-'Dex. The increase of MW (14,000, 24,000, and 42,000 g/mol) and Dex content (0, 151, and 313 μmol/g) enhances the arthrotropism of P-'Dex. For the conjugate with highest MW and Dex content (P-'H-M W/Dex), the percentage of injected doses per gram (ID/g) of ankle synovial tissue at day seventh postadministration is 1{\%} g -'1, which confirms P-'Dex as an arthrotropic macromolecular prodrug. For liver and spleen, the ID/g values are 0.51 and 3.64{\%} g -'1, respectively. As an antigen-presenting organ, the sequestration of the prodrug by spleen may be explained by its abnormal enlargement associated with the systemic inflammatory disease model. Gradual reduction of spleen weight due to the inflammation resolution effect of P-'Dex may also contribute to the high ID/g values. Increase of Dex content and reduction of MW would increase P-'Dex distribution to kidney. The highest ID/g value for kidney at day seventh postadministration (0.91{\%} g -'1) was found with P-'L-M w (MW = 14,000 g/mol, Dex content =288 μmol/g), which may suggest kidney tubuli reabsorption of the conjugates. The P-'Dex's distribution to heart and lung is minimum.",
keywords = "HPMA copolymer, Rheumatoid arthritis, arthrotropism, biodistribution, dexamethasone, pharmacokinetics, prodrug",
author = "Quan, {Ling Dong} and Fang Yuan and Liu, {Xin Ming} and Huang, {Jian Geng} and Yazen Alnouti and Dong Wang",
year = "2010",
month = "8",
day = "2",
doi = "10.1021/mp100132h",
language = "English (US)",
volume = "7",
pages = "1041--1049",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "4",

}

TY - JOUR

T1 - Pharmacokinetic and biodistribution studies of N -(2-hydroxypropyl) methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model

AU - Quan, Ling Dong

AU - Yuan, Fang

AU - Liu, Xin Ming

AU - Huang, Jian Geng

AU - Alnouti, Yazen

AU - Wang, Dong

PY - 2010/8/2

Y1 - 2010/8/2

N2 - N-(2-Hydroxypropyl)methacrylamide (HPMA) copolymer has been found to be arthrotropic (joint-targeting) in the adjuvant-induced arthritis (AA) rat model using magnetic resonance imaging (MRI). In this manuscript, we report the quantitative pharmacokinetics and biodistribution (PK/BD) of 125I-labeled HPMA copolymer-'dexamethasone conjugate (P-'Dex) in AA rats. Structural parameters of the prodrug such as the molecular weight (MW) and Dex content were found to have strong impact on the PK/BD profiles of P-'Dex. The increase of MW (14,000, 24,000, and 42,000 g/mol) and Dex content (0, 151, and 313 μmol/g) enhances the arthrotropism of P-'Dex. For the conjugate with highest MW and Dex content (P-'H-M W/Dex), the percentage of injected doses per gram (ID/g) of ankle synovial tissue at day seventh postadministration is 1% g -'1, which confirms P-'Dex as an arthrotropic macromolecular prodrug. For liver and spleen, the ID/g values are 0.51 and 3.64% g -'1, respectively. As an antigen-presenting organ, the sequestration of the prodrug by spleen may be explained by its abnormal enlargement associated with the systemic inflammatory disease model. Gradual reduction of spleen weight due to the inflammation resolution effect of P-'Dex may also contribute to the high ID/g values. Increase of Dex content and reduction of MW would increase P-'Dex distribution to kidney. The highest ID/g value for kidney at day seventh postadministration (0.91% g -'1) was found with P-'L-M w (MW = 14,000 g/mol, Dex content =288 μmol/g), which may suggest kidney tubuli reabsorption of the conjugates. The P-'Dex's distribution to heart and lung is minimum.

AB - N-(2-Hydroxypropyl)methacrylamide (HPMA) copolymer has been found to be arthrotropic (joint-targeting) in the adjuvant-induced arthritis (AA) rat model using magnetic resonance imaging (MRI). In this manuscript, we report the quantitative pharmacokinetics and biodistribution (PK/BD) of 125I-labeled HPMA copolymer-'dexamethasone conjugate (P-'Dex) in AA rats. Structural parameters of the prodrug such as the molecular weight (MW) and Dex content were found to have strong impact on the PK/BD profiles of P-'Dex. The increase of MW (14,000, 24,000, and 42,000 g/mol) and Dex content (0, 151, and 313 μmol/g) enhances the arthrotropism of P-'Dex. For the conjugate with highest MW and Dex content (P-'H-M W/Dex), the percentage of injected doses per gram (ID/g) of ankle synovial tissue at day seventh postadministration is 1% g -'1, which confirms P-'Dex as an arthrotropic macromolecular prodrug. For liver and spleen, the ID/g values are 0.51 and 3.64% g -'1, respectively. As an antigen-presenting organ, the sequestration of the prodrug by spleen may be explained by its abnormal enlargement associated with the systemic inflammatory disease model. Gradual reduction of spleen weight due to the inflammation resolution effect of P-'Dex may also contribute to the high ID/g values. Increase of Dex content and reduction of MW would increase P-'Dex distribution to kidney. The highest ID/g value for kidney at day seventh postadministration (0.91% g -'1) was found with P-'L-M w (MW = 14,000 g/mol, Dex content =288 μmol/g), which may suggest kidney tubuli reabsorption of the conjugates. The P-'Dex's distribution to heart and lung is minimum.

KW - HPMA copolymer

KW - Rheumatoid arthritis

KW - arthrotropism

KW - biodistribution

KW - dexamethasone

KW - pharmacokinetics

KW - prodrug

UR - http://www.scopus.com/inward/record.url?scp=77955251366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955251366&partnerID=8YFLogxK

U2 - 10.1021/mp100132h

DO - 10.1021/mp100132h

M3 - Article

C2 - 20557133

AN - SCOPUS:77955251366

VL - 7

SP - 1041

EP - 1049

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 4

ER -